Correlation Between Cue Biopharma and Bioatla
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Bioatla, you can compare the effects of market volatilities on Cue Biopharma and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Bioatla.
Diversification Opportunities for Cue Biopharma and Bioatla
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cue and Bioatla is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Bioatla go up and down completely randomly.
Pair Corralation between Cue Biopharma and Bioatla
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Bioatla. In addition to that, Cue Biopharma is 1.03 times more volatile than Bioatla. It trades about -0.26 of its total potential returns per unit of risk. Bioatla is currently generating about -0.15 per unit of volatility. If you would invest 209.00 in Bioatla on August 29, 2024 and sell it today you would lose (52.00) from holding Bioatla or give up 24.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Bioatla
Performance |
| Timeline |
| Cue Biopharma |
| Bioatla |
Cue Biopharma and Bioatla Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Bioatla
The main advantage of trading using opposite Cue Biopharma and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world |